A Study to Evaluate AGN-151586 Intramuscular Injections in Adult Participants for Treatment of Glabellar Lines

PHASE3CompletedINTERVENTIONAL
Enrollment

161

Participants

Timeline

Start Date

March 29, 2024

Primary Completion Date

February 26, 2025

Study Completion Date

February 26, 2025

Conditions
Glabellar Lines
Interventions
DRUG

AGN-151586

Intramuscular Injections

DRUG

Placebo

Intramuscular Injections

Trial Locations (12)

807

Kaohsiung Medical University Chung-Ho Memorial Hospital /ID# 260669, Kaohsiung City

11490

Tri-Service General Hospital /ID# 260673, Taipei

100730

Beijing Hospital /ID# 256084, Beijing

200040

Huashan Hospital, Fudan University /ID# 255870, Shanghai

210008

Nanjing Drum Tower Hospital /ID# 255936, Nanjing

210009

Zhongda Hospital Southeast University /ID# 255937, Nanjing

214023

Wuxi People's Hospital /ID# 256029, Wuxi

310014

Zhejiang Provincial People's Hospital /ID# 256028, Hangzhou

430022

Union Hospital Tongji Medical College Huazhong University of Science and Technol /ID# 255871, Wuhan

510091

Dermatology Hospital of Southern Medical University /ID# 256172, Guangzhou

712000

Xianyang Hospital of Yan'an University /ID# 256774, Xianyang

103-0027

Tokyo Center Clinic /ID# 267380, Chuo-ku

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AbbVie

INDUSTRY